Multi-drug resistant bacteria: When the immune system during COVID-19 is attacked from two fronts
SHARE YOUR SCIENCE: Norwegian COVID-19 patients who get a secondary bacterial infection leading to pneumonia, are better equipped in their struggle against this than Italian patients. Are we doing enough to find new technology against multi-drug resistant bacteria?
Experts want to free medical research and healthcare from ties to the commercial pharmaceutical industry
Pharmaceutical companies are behind much of the research on new drugs and have an influence on medical education and guidelines for treatments. It’s time for this to change, a group of international scientists says.